Impact of the COVID-19 pandemic on routine vaccine landscape: A global perspective

S Basu, G Ashok, R Debroy, S Ramaiah… - Human Vaccines & …, 2023 - Taylor & Francis
ABSTRACT The coronavirus disease (COVID-19) threat is subsiding through extensive
vaccination worldwide. However, the pandemic imposed major disruptions in global …

Use of inactivated poliovirus vaccine for poliovirus outbreak response

AS Bandyopadhyay, RL Cavestany… - The Lancet Infectious …, 2024 - thelancet.com
With continued wild poliovirus transmission in Afghanistan and Pakistan and circulating
vaccine-derived poliovirus in certain countries, there exists an ongoing risk of importation of …

Modeling undetected poliovirus circulation following the 2022 outbreak in the United States

DA Kalkowska, K Badizadegan, JA Routh… - Expert Review of …, 2024 - Taylor & Francis
ABSTRACT Background New York State (NYS) reported a polio case (June 2022) and
outbreak of imported type 2 circulating vaccine-derived poliovirus (cVDPV2)(last positive …

Current perspectives on the diagnosis and management of acute transverse myelitis

N Tisavipat, EP Flanagan - Expert review of neurotherapeutics, 2023 - Taylor & Francis
Introduction Acute transverse myelitis (ATM) is a term that encompasses a wide range of
etiologies from immune-mediated to infectious. Management and prognosis differ for each …

IL-23 receptor signaling licenses group 3-like innate lymphoid cells to restrict a live-attenuated oral Chlamydia vaccine in the gut

Y He, Y Wang, R He, AM Abdelsalam… - Infection and …, 2023 - Am Soc Microbiol
An IFNγ-susceptible mutant of Chlamydia muridarum is attenuated in pathogenicity in the
genital tract and was recently licensed as an intr acellular O ral vaccine v ector or intrOv …

Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in …

KM Thompson, DA Kalkowska, SE Kidd, CC Burns… - Vaccine, 2024 - Elsevier
Delays in achieving polio eradication have led to ongoing risks of poliovirus importations
that may cause outbreaks in polio-free countries. Because of the low, but non-zero risk of …

Preclinical screen for protection efficacy of chlamydial antigens that are immunogenic in humans

C Lu, J Wang, G Zhong - Infection and immunity, 2023 - Am Soc Microbiol
To search for subunit vaccine candidates, immunogenic chlamydial antigens identified in
humans were evaluated for protection against both infection and pathology in a mouse …

Analysis of a Sabin-strain inactivated poliovirus vaccine response to a circulating type 2 vaccine-derived poliovirus event in Sichuan Province, China 2019-2021

H Yang, Q Qi, Y Zhang, N Wen, L Cao, Y Liu… - JAMA Network …, 2023 - jamanetwork.com
Importance The Sabin-strain inactivated poliovirus vaccine (IPV) may be a tool for polio
outbreak response in certain situations. Objective To investigate the response to a type 2 …

Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and …

CJ Snider, K Zaman, AL Wilkinson, AB Aziz, M Yunus… - Vaccine, 2023 - Elsevier
Background To inform response strategies, we examined type 1 humoral and intestinal
immunity induced by 1) one fractional inactivated poliovirus vaccine (fIPV) dose given with …

Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance

RW Sutter, M Eisenhawer, NA Molodecky, H Verma… - Pathogens, 2024 - mdpi.com
Inactivated poliovirus vaccine (IPV), available since 1955, became the first vaccine to be
used to protect against poliomyelitis. While the immunogenicity of IPV to prevent paralytic …